LMR Partners’s LumiraDx Limited Warrant LMDXW Stock Holding History

LMR Partners’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-200,600	Closed	-$1.73K	–	1392
2023 Q4	$1.73K	Hold	200,600	–	–	﹤0.01%	941
2023 Q3	$5.82K	Hold	200,600	–	–	﹤0.01%	859
2023 Q2	$6K	Hold	200,600	–	–	﹤0.01%	802
2023 Q1	$93.3K	Hold	200,600	–	–	﹤0.01%	946
2022 Q4	$181K	Hold	200,600	–	–	﹤0.01%	1007
2022 Q3	$205K	Hold	200,600	–	–	﹤0.01%	1012
2022 Q2	$534K	Hold	200,600	–	–	0.01%	897
2022 Q1	$1.2M	Hold	200,600	–	–	0.01%	741
2021 Q4	$1.79M	Buy	200,600 +100,000	+99%	+$161K	0.02%	514
2021 Q3	$832K	Buy	+100,600	New	+$117K	0.01%	687

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

LMR Partners's LMDXW Position: Q1 2024 in Review

LMR Partners sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2024, closing a stake of 200,600 shares — an estimated $1.73K sold.

LMR Partners first reported a position in LMDXW in Q3 2021 and held it in 10 quarters. The position peaked at $1.79M in Q4 2021. 4 funds tracked by Wall St. Rank hold LMDXW as of Q1 2024.

LMR Partners reported no remaining LumiraDx Limited Warrant position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 200,600 LumiraDx Limited Warrant shares in Q1 2024, an estimated $1.73K.
LMR Partners first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 10 quarters.
LMR Partners's LumiraDx Limited Warrant position peaked at $1.79M in Q4 2021.
4 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.